Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group

NGM Biopharmaceuticals

26/02/2024 14:13

Feb 26 (Reuters) - NGM Biopharmaceuticals Inc  NGM.O :
    * NGM BIO HAS ENTERED INTO A DEFINITIVE AGREEMENT AND PLAN
OF
MERGER WITH CERTAIN AFFILIATES OF THE COLUMN GROUP, LP
    * NGM BIOPHARMACEUTICALS INC - NGM BIO STOCKHOLDERS TO
RECEIVE
$1.55 PER SHARE IN CASH
    * NGM BIOPHARMACEUTICALS INC - IF COMPLETED, TRANSACTION
WILL
RESULT IN NGM BIO BECOMING A PRIVATELY HELD COMPANY
    * NGM BIOPHARMACEUTICALS INC - NGM BIO'S CASH, CASH
EQUIVALENTS
AND SHORT-TERM MARKETABLE SECURITIES WERE ESTIMATED $144.2
MILLION AS OF DECEMBER 31, 2023
    * NGM BIOPHARMACEUTICALS - IF COMPLETED, DEAL WILL RESULT IN
NGM
BIO BECOMING A PRIVATELY HELD COMPANY AND ITS SHARES WILL NO
LONGER BE LISTED ON NASDAQ.
    * NGM BIOPHARMACEUTICALS INC - PRICE PER SHARE FOR DEAL
CORRESPONDS TO A TOTAL EQUITY VALUE OF $135 MILLION ON A FULLY
DILUTED BASIS

Source text for Eikon:  ID:nGNX2VSz7k 
Further company coverage:  NGM.O 

 ((Reuters.Briefs@thomsonreuters.com;))